» Articles » PMID: 11433041

Bisulfite Genomic Sequencing: Systematic Investigation of Critical Experimental Parameters

Overview
Specialty Biochemistry
Date 2001 Jul 4
PMID 11433041
Citations 293
Authors
Affiliations
Soon will be listed here.
Abstract

Bisulfite genomic sequencing is the method of choice for the generation of methylation maps with single-base resolution. The method is based on the selective deamination of cytosine to uracil by treatment with bisulfite and the sequencing of subsequently generated PCR products. In contrast to cytosine, 5-methylcytosine does not react with bisulfite and can therefore be distinguished. In order to investigate the potential for optimization of the method and to determine the critical experimental parameters, we determined the influence of incubation time and incubation temperature on the deamination efficiency and measured the degree of DNA degradation during the bisulfite treatment. We found that maximum conversion rates of cytosine occurred at 55 degrees C (4-18 h) and 95 degrees C (1 h). Under these conditions at least 84-96% of the DNA is degraded. To study the impact of primer selection, homologous DNA templates were constructed possessing cytosine-containing and cytosine-free primer binding sites, respectively. The recognition rates for cytosine (>/=97%) and 5-methylcytosine (>/=94%) were found to be identical for both templates.

Citing Articles

Genomic and fragmentomic landscapes of cell-free DNA for early cancer detection.

Bruhm D, Vulpescu N, Foda Z, Phallen J, Scharpf R, Velculescu V Nat Rev Cancer. 2025; .

PMID: 40038442 DOI: 10.1038/s41568-025-00795-x.


Double and single stranded detection of 5-methylcytosine and 5-hydroxymethylcytosine with nanopore sequencing.

Halliwell D, Honig F, Bagby S, Roy S, Murrell A Commun Biol. 2025; 8(1):243.

PMID: 39955446 PMC: 11830040. DOI: 10.1038/s42003-025-07681-0.


Methylome profiling of cell-free DNA during the early life course in (un)complicated pregnancies using MeD-seq: Protocol for a cohort study embedded in the prospective Rotterdam periconception cohort.

van Vliet M, Schoenmakers S, Boers R, van der Meeren L, Gribnau J, Steegers-Theunissen R PLoS One. 2025; 20(1):e0310019.

PMID: 39787204 PMC: 11717202. DOI: 10.1371/journal.pone.0310019.


Non-invasive prenatal diagnosis (NIPD): current and emerging technologies.

Hanson B, Paternoster B, Povarnitsyn N, Scotchman E, Chitty L, Chandler N Extracell Vesicles Circ Nucl Acids. 2024; 4(1):3-26.

PMID: 39698301 PMC: 11648410. DOI: 10.20517/evcna.2022.44.


A review of cell-free DNA and epigenetics for non-invasive diagnosis in solid organ transplantation.

Sebastian A, Silvy M, Coiffard B, Reynaud-Gaubert M, Magdinier F, Chiaroni J Front Transplant. 2024; 3:1474920.

PMID: 39619700 PMC: 11605403. DOI: 10.3389/frtra.2024.1474920.


References
1.
Rohde A, Grunau C, De Beck L, Van Montagu M, Rosenthal A, Boerjan W . Carpel, a new Arabidopsis epi-mutant of the SUPERMAN gene: phenotypic analysis and DNA methylation status. Plant Cell Physiol. 1999; 40(9):961-72. DOI: 10.1093/oxfordjournals.pcp.a029629. View

2.
Paulin R, GRIGG G, Davey M, Piper A . Urea improves efficiency of bisulphite-mediated sequencing of 5'-methylcytosine in genomic DNA. Nucleic Acids Res. 1998; 26(21):5009-10. PMC: 147923. DOI: 10.1093/nar/26.21.5009. View

3.
Sono M, Wataya Y, Hayatsu H . Role of bisulfite in the deamination and the hydrogen isotope exchange of cytidylic acid. J Am Chem Soc. 1973; 95(14):4745-9. DOI: 10.1021/ja00795a044. View

4.
SANGER F, Nicklen S, Coulson A . DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A. 1977; 74(12):5463-7. PMC: 431765. DOI: 10.1073/pnas.74.12.5463. View

5.
Wang R, GEHRKE C, Ehrlich M . Comparison of bisulfite modification of 5-methyldeoxycytidine and deoxycytidine residues. Nucleic Acids Res. 1980; 8(20):4777-90. PMC: 324387. DOI: 10.1093/nar/8.20.4777. View